Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Smith & Nephew Plc
  6. Company
    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Smith & Nephew Plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Number of employees : 17 914 people.
Sales per Business
20192020Delta
GBP (in Million)%GBP (in Million)%
Orthopedics1,74243.2%1,49542% -14.17%
Sports Medicine & Ear, Nose and Throat1,20429.9%1,03929.2% -13.66%
Advanced Wound Management1,08226.9%1,02228.7% -5.56%
Sales per region
20192020Delta
GBP (in Million)%GBP (in Million)%
United States2,00049.6%1,82451.3% -8.78%
Established Markets1,11227.6%1,00128.2% -9.98%
Emerging Markets486.7812.1%353.269.9% -27.43%
China263.386.5%247.987% -5.85%
United Kingdom165.394.1%129.453.6% -21.73%
Managers
NameAgeSinceTitle
Roland Diggelmann532019Chief Executive Officer & Non-Executive Director
Anne-Francoise Nesmes492020Chief Financial Officer & Executive Director
Vasant Padmanabhan532016President-Research & Development
Mark Gladwell452019President-Global Operations & Business Services
Catheryn O'Rourke482018Chief Legal & Compliance Officer
Erik Nils Engstrom572015Independent Non-Executive Director
Robin Freestone612019Senior Independent Non-Executive Director
Angela Susan Risley622017Independent Non-Executive Director
Marc E. Owen612017Independent Non-Executive Director
Charles Richard Kenneth Medlock602020Independent Non-Executive Director
Members of the board
NameAgeSinceTitle
Roberto Quarta722014Chairman
Erik Nils Engstrom572015Independent Non-Executive Director
Robin Freestone612019Senior Independent Non-Executive Director
Angela Susan Risley622017Independent Non-Executive Director
Marc E. Owen612017Independent Non-Executive Director
Roland Diggelmann532019Chief Executive Officer & Non-Executive Director
Charles Richard Kenneth Medlock602020Independent Non-Executive Director
Robert White572020Independent Non-Executive Director
Anne-Francoise Nesmes492020Chief Financial Officer & Executive Director
Katarzyna Mazur-Hofsaess, Dr.572020Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 888,197,682 876,745,471 98.7% 9,100,000 1.0% 98.7%
Shareholders
NameEquities%
Wellington Management Co. LLP 42,665,590 4.85%
Thornburg Investment Management, Inc. 28,282,441 3.22%
WCM Investment Management LLC 27,168,133 3.09%
BlackRock Fund Advisors 24,767,742 2.82%
The Vanguard Group, Inc. 20,714,542 2.36%
Norges Bank Investment Management 19,781,000 2.25%
Walter Scott & Partners Ltd. 19,706,202 2.24%
Fidelity Management & Research Co. LLC 17,746,881 2.02%
Rathbone Investment Management Ltd. 16,350,000 1.86%
Legal & General Investment Management Ltd. 10,880,927 1.24%
Holdings
NameEquities%Valuation
Bioventus, Inc. 15,786,737100.0%280,688,184 USD
Bioventus Inc. (BVS) 6,229,99115.2%110,769,240 USD
Bioventus, Inc. 16,534,814
Markets and indexes
-
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, STOXX Europe 600, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  SN/:LN
- Reuters Code :  SN.L
- Datastream Code :  
Company contact information
Smith & Nephew Plc
Building 5 Croxley Park
WD18 8YE Watford, Hertfordshire


Phone : +44 20 7401 7646
Fax : +44 20 7960 2356
web site : http://www.smith-nephew.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Smith & Nephew Plc